Analyst Consensus ?
ConsensusBuy42 ratings
Bullish2354.8%
Neutral1945.2%
Bearish00.0%
The Hartford Insurance Group, Inc. · HIG · FY2026 Q2 · Calendar Q3 2026
The Hartford Beats on Q2 Core Earnings, Divests Hartford Funds, Expands Buyback to $4.2B
The Hartford delivered a strong second quarter with $945 million in core earnings and an 18.7% trailing ROE, beating EPS estimates by 8.2% and revenue estimates by 1.3%. The standout strategic move was the divestiture of Hartford Funds to Wellington Management, monetizing a non-core asset and freeing capital for an expanded $4.2 billion share repurchase authorization through 2028. Net investment income surged 22% year over year to $800 million, driven by limited partnership returns. Small commercial premium growth of 7% outpaced the market, supported by AI-enabled underwriting and continued agency channel expansion to 23 states. Pressure points include personal lines pricing headwinds, elevated disability loss ratios, and higher reserves in general liability and commercial auto.
Reported After market closeNYSEFinancial Services
$39.94B market cap
100quality score
Company context
Snapshot as of publicationThe Hartford Insurance Group, Inc., together with its subsidiaries, provides insurance and financial services to individual and business customers in the United States, the United Kingdom, and internationally. It operates through Business Insurance, Personal Insurance, Property & Casualty Other Operations, Employee Benefits and Hartford Funds. The company offers insurance coverage, including workers’ compensation, property, automobile, general and professional liability, package business, umbrella, fidelity and surety, marine, livestock, accident, health, and reinsurance through regional offices, branches, sales and policyholder service centers, independent retail agents and brokers, wholesale agents, and reinsurance brokers. The company also provides automobiles, homeowners, and personal umbrella coverages. The Property & Casualty Other Operations segment offers coverage for asbestos and environmental exposures.…
Earnings scorecard
Reported versus consensus
Reported EPS
$3.42
Consensus $3
EPS surprise
+8.2%
Reported versus consensus
Reported revenue
$7.26B
Consensus $7.17B
Revenue surprise
+1.3%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$145.68Previous close
$73Low
$131.61Average
$165High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 28, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 27, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 27, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Piper Sandler | Neutral | Overweight | Downgrade | Jul 15, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 10, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 9, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 12, 2026 |
| UBS | Buy | Buy | Maintain | Apr 27, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Feb 4, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Feb 3, 2026 |
| Roth Capital | Neutral | Neutral | Maintain | Jan 30, 2026 |
| Argus Research | Buy | Buy | Maintain | Nov 25, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 1, 2025 |
| Jefferies | Hold | Hold | Maintain | Apr 11, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Nov 27, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 13, 2024 |
| Roth MKM | Neutral | Neutral | Maintain | Apr 26, 2024 |
| TD Cowen | Buy | Buy | Maintain | Apr 3, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 17, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | May 5, 2020 |
| MKM Partners | Buy | Buy | Maintain | Apr 30, 2020 |
| Buckingham Research | Neutral | Buy | Downgrade | Jan 22, 2020 |
| Buckingham | Neutral | Buy | Downgrade | Jan 22, 2020 |
| B. Riley Securities | Buy | Buy | Maintain | Jun 26, 2019 |
| B. Riley | Buy | Buy | Maintain | Jun 26, 2019 |
| Compass Point | Buy | Buy | Maintain | Jan 15, 2019 |
| B. Riley FBR | Buy | Neutral | Upgrade | Sep 24, 2018 |
| Sandler O'Neill | Buy | Buy | Maintain | Sep 10, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| FBR Capital | Market Perform | Outperform | Downgrade | Nov 28, 2016 |
| Bank of America | Neutral | Buy | Downgrade | Nov 16, 2016 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Aug 10, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Aug 1, 2016 |
| Nomura | Neutral | Neutral | Maintain | Jan 19, 2016 |
| Sterne Agee | Buy | Buy | Maintain | Oct 13, 2014 |
| Stifel Nicolaus | Buy | Buy | Maintain | Dec 27, 2012 |
| Stifel | Buy | Buy | Maintain | Dec 27, 2012 |
| Bank oferica | Buy | Buy | Maintain | Feb 24, 2012 |
| Evercore Partners | Overweight | Overweight | Maintain | Feb 16, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $145.68. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Paul Newsome | $146 | $138.15 | +0.2% | Jul 15, 2026 |
| Mizuho Securities | Yaron Kinar | $154 | $127.33 | +5.7% | Jun 5, 2026 |
| Wells Fargo | Elyse Greenspan | $154 | $127.33 | +5.7% | Jun 5, 2026 |
| Morgan Stanley | Analyst unavailable | $142 | $139.38 | -2.5% | Feb 3, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $165 | $136.38 | +13.3% | Feb 2, 2026 |
| UBS | Analyst unavailable | $157 | $135.06 | +7.8% | Feb 2, 2026 |
| Wells Fargo | Analyst unavailable | $156 | $135.06 | +7.1% | Feb 1, 2026 |
| Roth Capital | Analyst unavailable | $135 | $132.37 | -7.3% | Jan 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $160 | $132.44 | +9.8% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $153 | $135.24 | +5.0% | Jan 13, 2026 |
| Goldman Sachs | Robert Cox | $151 | $135.9 | +3.7% | Jan 7, 2026 |
| Evercore ISI | David Motemaden | $145 | $136.86 | -0.5% | Jan 7, 2026 |
| Piper Sandler | Analyst unavailable | $161 | $139.01 | +10.5% | Dec 22, 2025 |
| Mizuho Securities | Analyst unavailable | $160 | $138.65 | +9.8% | Dec 15, 2025 |
| UBS | Brian Meredith | $155 | $129.43 | +6.4% | Dec 8, 2025 |
| Argus Research | Kevin Heal | $155 | $138.37 | +6.4% | Nov 25, 2025 |
| RBC Capital | Analyst unavailable | $145 | $136.64 | -0.5% | Nov 24, 2025 |
| Morgan Stanley | Bob Huang | $150 | $133.06 | +3.0% | Nov 17, 2025 |
| UBS | Brian Meredith | $152 | $133.81 | +4.3% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $160 | $133.81 | +9.8% | Oct 8, 2025 |
| Morgan Stanley | Analyst unavailable | $140 | $133.48 | -3.9% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $137 | $134.24 | -6.0% | Oct 1, 2025 |
| Piper Sandler | Analyst unavailable | $150 | $131.91 | +3.0% | Sep 2, 2025 |
| Evercore ISI | David Motemaden | $123 | $112.3 | -15.6% | Feb 3, 2025 |
| Capital One Financial | Michael Zaremski | $141 | $124.03 | -3.2% | Nov 27, 2024 |
| Jefferies | Yaron Kinar | $126 | $113.48 | -13.5% | Oct 28, 2024 |
| Bank of America Securities | Joshua Shanker | $121 | $116.66 | -16.9% | Oct 4, 2024 |
| Barclays | Alex Scott | $130 | $116 | -10.8% | Sep 4, 2024 |
| Jefferies | Yaron Kinar | $113 | $109.26 | -22.4% | Jul 29, 2024 |
| Citigroup | Michael Ward | $118 | $109.26 | -19.0% | Jul 29, 2024 |
| Piper Sandler | Paul Newsome | $125 | $109.44 | -14.2% | Jul 29, 2024 |
| RBC Capital | Mark Dwelle | $115 | $109.41 | -21.1% | Jul 29, 2024 |
| Goldman Sachs | Robert Cox | $111 | $99.4 | -23.8% | Jun 13, 2024 |
| Argus Research | Jacob Kilstein | $110 | $101.33 | -24.5% | May 15, 2024 |
| CFRA | Catherine Seifert | $115 | $99.46 | -21.1% | Mar 13, 2024 |
| Barclays | Tracy Benguigui | $78 | $63.45 | -46.5% | Aug 4, 2022 |
| Raymond James | Analyst unavailable | $85 | $70.15 | -41.7% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $89 | $69.93 | -38.9% | May 2, 2022 |
| Bank of America Securities | Joshua Shanker | $86 | $72.13 | -41.0% | Oct 29, 2021 |
| Credit Suisse | Andrew Kligerman | $93 | $67.86 | -36.2% | Sep 9, 2021 |
| Deutsche Bank | Phil Stefano | $73 | $62.28 | -49.9% | Jul 12, 2021 |
| Raymond James | Charles Peters | $75 | $65.3 | -48.5% | Apr 19, 2021 |
| Piper Sandler | Nicole Miller Regan | $75 | $65.09 | -48.5% | Apr 12, 2021 |
Track every rating change on HIG the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-1.2%
Event window
SPY move
+0.1%
Same window
Abnormal move
-1.3%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
+3.7%
Up to 20 sessions
HIGSPY benchmark
Follow HIG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
EPS came in at $3.42 versus $3.16 estimated (8.2% surprise), while revenue reached $7.26 billion versus $7.17 billion estimated (1.3% surprise). Compared to Q1 2026's $866 million in core earnings and 20.3% trailing ROE, Q2 core earnings rose to $945 million, though trailing ROE moderated to 18.7%. The company completed the Hartford Funds sale to Wellington Management, replacing the prior quarter's smaller buyback pace with a new $4.2 billion authorization through 2028. Net investment income jumped to $800 million from $739 million in Q1, lifted by limited partnership returns. The agency product rollout advanced from 15 states in Q1 to 23 states in Q2, targeting roughly 30 states. The stock initially fell 1.3% on the report but drifted higher by 3.7% over subsequent sessions on 1.6x baseline volume.
Guidance delta
Management maintained its guidance sentiment, consistent with Q1. No explicit change to expense-ratio targets, with 2027 capital-efficiency goals still in focus. The forward-looking plan to repurchase approximately $475 million per quarter through 2026 replaces the prior $450 million quarterly pace, reflecting the enlarged authorization.
Key takeaways
- Core earnings of $945 million with 18.7% trailing ROE, driven by premium growth and investment income.
- EPS of $3.42 beat the $3.16 consensus estimate by 8.2%; revenue of $7.26 billion beat by 1.3%.
- Hartford Funds divestiture to Wellington Management monetizes a non-core asset and supports the expanded $4.2 billion buyback.
- Net investment income rose 22% YoY to $800 million on limited partnership returns.
- Small commercial premium growth of 7% outpaced the market, aided by AI-enabled underwriting and digital services.
- Agency product rollout reached 23 states, targeting roughly 30 states.
Management priorities
- Invest in AI, automation, and digital underwriting capabilities.
- Complete the agency product rollout to roughly 30 states.
- Execute approximately $475 million in quarterly share repurchases through 2026.
- Pursue organic growth and new product development rather than M&A.
- Meet 2027 capital-efficiency and expense-ratio targets.
Related earnings events
Financial ServicesAXP · FY2026 Q2 · Calendar Q3 2026AXP Q2 2026: Platinum Card Drives 10% Revenue Growth, Full-Year Guidance RaisedAMP · FY2026 Q2 · Calendar Q3 2026Ameriprise Q2 2026: Revenue Up 13%, EPS Beats on Record AUM and AI-Driven ProductivityNDAQ · FY2026 Q2 · Calendar Q3 2026Nasdaq Q2: Revenue Up 15%, EPS Beats by 9%, Index AUM Crosses $1 Trillion
Sources
- Earnings call transcript and parsed analysis · 2026-07-24T15:04:42.272562+00:00
- FN2 earnings calendar · 2026-07-30T01:23:13.872335+00:00
- Polygon adjusted daily market bars · 2026-07-30T05:50:52.147638+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T05:50:52.145024+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.